Back to News
Market Impact: 0.22
MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'
Source: PR Newswire
Artificial IntelligenceTechnology & InnovationHealthcare & Biotech
A South Korean consortium involving Hanmi Pharmaceutical, Samsung SDS, and Selectstar is deploying a fine-tuned Korean Solar AI model on AIR Studio to automate pharmaceutical quality-document operations. The initiative is part of South Korea's MSIT-NIPA AX One-Stop Voucher Program, signaling targeted enterprise AI adoption in regulated life-sciences workflows.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.32
More News
- Nvidia in talks to invest up to $10 billion in Anthropic IPO
- Apollo in talks to buy J&J orthopedics unit for nearly $20 billion
- Wall Street thought the Powell hike was over. Now Kevin Warsh has his ‘back against the wall’
- Exclusive-Nvidia in talks to invest in Anthropic’s mega IPO, sources say
- Here’s the inflation breakdown for August 2026 — in one chart
- Why ACV Stock Rocketed 44% Higher Today